ABSTRACT OBJECTIVES This study sought to determine the use of intravenous fluids in the early care of patients with acute decompensated heart failure (HF) who are treated with loop diuretics.
M
any signs and symptoms of heart failure (HF) are the result of volume overload (1) . Diuretic therapy, which reduces excess volume, is the most common treatment applied to improve symptoms and cardiovascular function (2, 3) .
For patients treated with diuretics, the administration of intravenous fluids is counterintuitive. Although some studies have investigated the benefits of co-administration of small volumes of hypertonic saline (4, 5) , the guidelines generally suggest fluid restriction for patients with HF and do not generally recommend intravenous fluid therapy (6) (7) (8) . However, intravenous fluids are routinely administered to hospitalized patients (9, 10) We defined intravenous fluid use as any use $500 ml of normal saline, half-normal saline solution, Ringer's/lactated Ringer's, or a combination of these solutions during the first 2 days of hospitalization, STATISTICAL ANALYSES. We calculated summary statistics for categorical variables using frequencies and percentages. We used a chi-square test to determine differences between treatment groups for unadjusted outcomes and hierarchical logistic regression to calculate adjusted odds ratios for all outcomes and to calculate hospital-level fluid utilization rates. We calculated odds ratios and 95% confidence intervals (CIs) of the fluid treatment versus no fluid treatment group for each outcome. Each patient could have been hospitalized more than once during the study period, although the majority had a single hospitalization. We used all hospitalizations when calculating odds ratios for renal replacement therapy, admission to an intensive care unit, and late intubation, and 1 randomly selected hospitalization per patient when calculating odds ratios for in-hospital mortality. We adjusted for clinically pre-specified patient characteristics and comorbidities ( Table 1) The majority of patients were older than 75 years (57%), female (53%), and white (63%) ( Table 1 ). The most common comorbidity was hypertension (70%), followed by diabetes (45%). The group that received intravenous fluids had demographic characteristics that were similar to those of the group that did not receive intravenous fluids (see Table 1 ). Table 3) .
METHODS

TREATMENT WITH INTRAVENOUS FLUIDS ACROSS
HOSPITALS. Across hospitals with at least 25 HF hospitalizations during the study period, the riskstandardized fluid utilization rate ranged from 0% to 71.1%, with a median of 12.5% ( Figure 2 ).
DISCUSSION
Among hospitalizations for acute decompensated HF in which patients were treated with loop diuretics in the first 2 days, we found that 11% were also given volumes of intravenous fluids (median: 1,000 ml) that were neither negligible nor used primarily for administration of other therapies. The remarkable variation among hospitals suggests that factors Bikdeli et al.
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Intravenous Fluids in Heart Failure We observed higher rates of late critical care admission, late intubation, late renal replacement Mixed † 892 (6) Values are n (%). *Defined as any combination of loop diuretics. †Defined as any combination of intravenous fluids. Values are odds ratio (95% confidence interval). *Includes admission to step-down units.
†All patients were treated with loop diuretics. 
